Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_assertion type Assertion NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_head.
- NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_assertion description "[Our findings suggest that HtrA1 is a downexpressed molecule since an early stage of bladder urothelial carcinoma development and that urinary HtrA1 protein may be considered, if successfully validated, as an early and highly sensitive and specific biomarker for this neoplasia (the sensitivity and specificity of HtrA1 are 92.65% and 95.59%, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_provenance.
- NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_assertion evidence source_evidence_literature NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_provenance.
- NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_assertion SIO_000772 23712470 NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_provenance.
- NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_assertion wasDerivedFrom befree-20150227 NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_provenance.
- NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_assertion wasGeneratedBy ECO_0000203 NP650047.RAy2vWIFatSl9gDfS50emhJW8LTsbBoktc50QmeOhMDRU130_provenance.